The U. S. Court of Appeals for the 2nd Circuit has ruled that two nonprofit pro-life pregnancy centers in New York can continue providing information about using progesterone for abortion pill reversal amid a legal dispute initiated by the New York Attorney General.
• Background of the Case: In 2024, New York Attorney General Letitia James sued 11 pro-life pregnancy centers, claiming they disseminated false information about the use of progesterone to reverse the effects of the abortion pill mifepristone.
• Legal Response: The centers, represented by Alliance Defending Freedom (ADF), filed a lawsuit asserting their right to free speech and the importance of informing women about possible abortion pill reversal.
• Court's Findings: The court ruled in favor of the pregnancy centers, determining that their speech is protected under the First Amendment and is not commercial in nature since it is based on religious and moral beliefs rather than financial gain.
• Importance of Information: ADF noted that many women who regret their abortions should have access to truthful information about the potential to save their babies' lives using progesterone, which has demonstrated a success rate of 64-68%.
The ruling allows these pregnancy centers to inform women about progesterone as a potential lifesaving option, amid ongoing legal challenges against the New York Attorney General's attempts to restrict their speech.
No comments:
Post a Comment